Latest News
|
22 May 2013
1 Likes 
As any regulatory professional can attest, finding information on the US Food and Drug Administration's (FDA) website is difficult—really, really difficult, even.So difficult, in fact, that it has
Read More...
Latest News
|
22 May 2013
0 Likes
The US Food and Drug Administration (FDA) has released a new manual of policies and procedures (MAPP) for its internal drug regulatory staff regarding the creation and maintenance of its electronic
Read More...
Latest News
|
22 May 2013
0 Likes
More than a few Warning Letters sent by the US Food and Drug Administration (FDA) over the years have referenced products that tried to skirt regulation by presenting themselves to regulators as a
Read More...
Latest News
|
22 May 2013
1 Likes
US regulators regularly send letters to industry regarding alleged transgressions, deficiencies and faults. The most common ones are well-known to the industry: Form 483s outline deficiencies found
Read More...
Latest News
|
22 May 2013
1 Likes
Emails sent by drug regulators working for the US Food and Drug Administration (FDA) are about to get a bit more standardized and a bit less annoying, according to a new internal staff policy posted
Read More...
Latest News
|
22 May 2013
1 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Accuracy of Blood Glucose Meters Draws FDA Scrutiny (KHN) (Medical Daily) Law Firm: FDA's
Read More...
Latest News
|
21 May 2013
1 Likes
The US Food and Drug Administration (FDA) is reaching out to the private sector in a bid to help it improve the quality of the postmarketing surveillance data it receives regarding biologic drugs and
Read More...
Latest News
|
21 May 2013
0 Likes
The medical device industry is weighing in on a recent guidance document published by the US Food and Drug Administration (FDA), in several instances calling it deeply flawed and in need of
Read More...
Latest News
|
21 May 2013
1 Likes
The US Food and Drug Administration (FDA) has released a copy of a warning letter sent last week to German pharmaceutical manufacturer Boehringer-Ingelheim, citing alleged manufacturing deficiencies
Read More...
Latest News
|
21 May 2013
1 Likes
US regulators have announced they will soon hold a lengthy meeting to discuss the possibility of standardizing the format and assessment process for risk evaluation and mitigation strategies (REMS), a
Read More...